Search Results

Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters.

• Authors : Straub JO; Group Safety, Health, and Environmental Protection, F.Hoffmann-La Roche, Basle, Switzerland.; Oldenkamp R

Subjects: Environmental Monitoring* ; Risk Assessment*; Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*analysis

• Source: Environmental toxicology and chemistry [Environ Toxicol Chem] 2019 Oct; Vol. 38 (10), pp. 2259-2278. Date of Electronic Publication: 2019 Sep 19.Publisher: SETAC Press Country of Publication: United States NLM ID: 8308958 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

[Second-line therapy with mycophenolate mofetil in patients with autoimmune hepatitis who were intolerant or failed to respond to standard treatment].

• Authors : Miura R; Department of Medicine, Teikyo University School of Medicine.; Yagi M

Subjects: Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/Hepatitis, Autoimmune*/drug therapy ; Mycophenolic Acid*/Mycophenolic Acid*/Mycophenolic Acid*/adverse effects; Adult

• Source: Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology [Nihon Shokakibyo Gakkai Zasshi] 2021; Vol. 118 (4), pp. 318-326.Publisher: Japanese Society Of Gastroenterology Country of Publication: Japan NLM ID: 2984683R Publication Model: Print Cited Medium: Print ISSN:

Record details

Mycophenolic acid and mycophenolic acid glucuronide trough levels after renal transplantation.

• Authors : Behrend M; Abteilung für Abdominal- und Transplantationschirurgie, Medizinische Hochschule Hannover, Germany.; Lueck R

Subjects: Glucuronates/Glucuronates/Glucuronates/*blood ; Glucuronates/Glucuronates/Glucuronates/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*blood

• Source: Transplantation proceedings [Transplant Proc] 1997 Nov; Vol. 29 (7), pp. 2936-8.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print Cited Medium: Print ISSN:

Record details

Effectiveness of Risk Minimization Measures to Prevent Pregnancy Exposure to Mycophenolate-Containing Medicines in Europe.

• Authors : Madison T; Scientific Medical Affairs, Mapi, an ICON plc company, Lexington, KY, USA. .; Donner B

Subjects: Health Knowledge, Attitudes, Practice*; Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*adverse effects ; Risk Management/Risk Management/Risk Management/*methods

• Source: Pharmaceutical medicine [Pharmaceut Med] 2019 Oct; Vol. 33 (5), pp. 395-406.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 101471195 Publication Model: Print Cited Medium: Internet ISSN:

Record details

A comparison of mycophenolate use in Australia and Northern Europe, and the impact on the pharmaceutical benefits scheme.

• Authors : Staatz CE; School of Pharmacy, University of Queensland, Queensland, Australia. ; Smith AJ

Subjects: Drug Utilization/Drug Utilization/Drug Utilization/*statistics & numerical data ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*therapeutic use

• Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2009 May; Vol. 18 (5), pp. 386-92.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

Mycophenolate: miscarriage and birth defects.

Subjects: Abortion, Spontaneous/Abortion, Spontaneous/Abortion, Spontaneous/*chemically induced ; Congenital Abnormalities/Congenital Abnormalities/Congenital Abnormalities/*etiology ; Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*adverse effects

• Source: Prescrire international [Prescrire Int] 2009 Feb; Vol. 18 (99), pp. 25.Publisher: Association Mieux Prescrire Country of Publication: France NLM ID: 9439295 Publication Model: Print Cited Medium: Print ISSN:

Record details

Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

• Authors : Mourad G; Glyda M ...

Subjects: Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*epidemiology ; Glucocorticoids/Glucocorticoids/Glucocorticoids/*administration & dosage ; Graft Rejection/Graft Rejection/Graft Rejection/*prevention & control

• Source: Transplantation [Transplantation] 2017 Aug; Vol. 101 (8), pp. 1924-1934.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

• Authors : Herrick AL; Centre for Musculoskeletal Research, The University of Manchester, Salford Royal NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*therapeutic use ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Methotrexate/Methotrexate/Methotrexate/*therapeutic use

• Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2017 Jul; Vol. 76 (7), pp. 1207-1218. Date of Electronic Publication: 2017 Feb 10.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

Individualization of immunosuppressive therapy. II. Sirolimus as a less nephrotoxic alternative to calcineurin inhibitors.

• Authors : Lisik W; Division of Immunology and Organ Transplantation, The University of Texas Health Science Center, 6431 Fannin, Houston, TX 77030, USA.; Kahan BD

Subjects: Immunosuppression Therapy/Immunosuppression Therapy/Immunosuppression Therapy/*methods ; Immunosuppressive Agents/Immunosuppressive Agents/Immunosuppressive Agents/*therapeutic use ; Kidney Transplantation/Kidney Transplantation/Kidney Transplantation/*immunology

• Source: Transplantation proceedings [Transplant Proc] 2006 Jan-Feb; Vol. 38 (1), pp. 69-73.Publisher: Elsevier Science Inc Country of Publication: United States NLM ID: 0243532 Publication Model: Print Cited Medium: Print ISSN:

Record details

Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services.

• Authors : Hoeltzenbein M; Pharmakovigilanzzentrum Embryonaltoxikologie, Charité Universitätsmedizin Berlin, Germany. ; Elefant E

Subjects: Mycophenolic Acid/Mycophenolic Acid/Mycophenolic Acid/*toxicity ; Teratogens/Teratogens/Teratogens/*toxicity; Abortion, Spontaneous

• Source: American journal of medical genetics. Part A [Am J Med Genet A] 2012 Mar; Vol. 158A (3), pp. 588-96. Date of Electronic Publication: 2012 Feb 08.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101235741 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details